Cynthia M. Butitta, Chief Operating Officer at Kite Pharma, Inc. (KITE), sold 9,300 shares at $78.10 ($723K) on 2017-03-27, disclosed to the SEC on 2017-03-28.
Open-market sale of $723k KITE by Chief Operating Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $77.23 | 4,375 | $338K | 46.8% |
| 2 | $78.10 | 4,925 | $385K | 53.2% |
| Total | $77.69 avg | 9,300 | $723K | 100% |
| Filing → |
| KITE | SELL | 2017-07-11 | $1.5M | — | Filing → |
| KITE | SELL | 2017-07-11 | $906K | — | Filing → |
| KITE | SELL | 2017-06-27 | $711K | — | Filing → |